Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer

Acta Oncologica
Anouk K M ClaessensDutch Breast Cancer Research Group (BOOG)

Abstract

Background: Previously, we showed that reintroduction of the same (first-line) chemotherapy at progression could only partially make up for the loss in efficacy as compared to continuously delivered first-line chemotherapy. Here, we report the probability of starting second-line study chemotherapy in the Stop&Go trial, and the progression-free survival (PFS) and overall survival (OS) of patients who received both the first- and second-line treatment in an intermittent versus continuous schedule.Methods: First-line chemotherapy comprised paclitaxel plus bevacizumab, second-line capecitabine or non-pegylated liposomal doxorubicin, given per treatment line as two times four cycles (intermittent) or as eight consecutive cycles (continuous).Results: Of the 420 patients who started first-line treatment within the Stop&Go trial (210:210), a total of 270 patients continued on second-line study treatment (64% of all), which consisted of capecitabine in 201 patients and of non-pegylated liposomal doxorubicin in 69 patients, evenly distributed between the treatment arms. Median PFS was 3.7 versus 5.0 months (HR 1.07; 95% CI: 0.82-1.38) and median OS 10.9 versus 12.4 months (HR 1.27; 95% CI: 0.98-1.66) for intermittent versus continuous se...Continue Reading

References

Jun 2, 1988·The New England Journal of Medicine·D M LaytonC R Bartram
Aug 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K PorkkaS Pyrhönen
Nov 1, 1993·British Journal of Cancer·W M GregoryR D Rubens
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B EjlertsenB Kristensen
Feb 21, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R K GregoryS Ashley
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FalksonM D Abeloff
Aug 30, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN French Epirubicin Study Group
Mar 12, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M A NooijUNKNOWN EORTC Breast Cancer Group
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alessandra GennariPier Franco Conte
Mar 24, 2007·Breast Cancer Research and Treatment·Armelle DufresneAimery De Gramont
May 19, 2007·The Breast : Official Journal of the European Society of Mastology·Udai BanerjiIan Smith
Sep 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Silvia DellapasquaMarco Colleoni
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Mar 26, 2009·Journal of the National Cancer Institute·Nadia HowladerBrenda K Edwards
Sep 29, 2009·Cancer Chemotherapy and Pharmacology·Elodie VauléonPierre Kerbrat
Apr 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alessandra GennariPaolo Bruzzi
Aug 20, 2011·The Breast : Official Journal of the European Society of Mastology·E PlanchatX Durando
Nov 2, 2013·Therapeutic Advances in Medical Oncology·Raffaella PalumboAntonio Bernardo
Dec 3, 2014·Clinical Breast Cancer·In Hae ParkJungsil Ro
Aug 5, 2015·Nature Reviews. Clinical Oncology·Elisabetta Munzone, Marco Colleoni
Nov 5, 2016·The Breast : Official Journal of the European Society of Mastology·Marie SundquistGöran Tejler
Aug 7, 2017·Clinical Breast Cancer·Marika CinauseroFabio Puglisi
Jul 23, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F CardosoE P Winer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.